刘媛博士自2019年1月起担任本公司疫苗研究负责人，主要负责疫苗佐剂的研发工作。其研究领域涵盖鼠兔乙型肝炎疫苗、人鼠兔狂犬病疫苗，以及正在开发的新型佐剂型肿瘤疫苗。在此之前，刘博士于2014年7月至2019年1月期间任职于益生兴业研发部，并2019年1月份起任益生兴业研究部副总裁。她专注于疫苗佐剂研究已超过十年，且在2016年获得北京市优秀人才培养基金青年骨干个人项目资助。

刘博士于 2008 年 7 月获中山大学学士学位，2014 年 7 月在中国科学院大学获得博士学位。

Head of Vaccine Research

Dr. Yuan Liu has served as our head of vaccine research since January 2019. She is responsible for the R&D of vaccine adjuvants, including PIKA hepatitis B vaccine, human PIKA rabies vaccine, and new adjuvant-based tumor vaccine under development.

Dr. Liu served as project leader of the R&D department at YS Group Xingye from July 2014 to January 2019 and has served as vice president of the research department at YS Group Xingye since January 2019. She has focused on the research of vaccine adjuvants for over 10 years. In 2016, she received the sponsorship of the Young Backbone Individual Project from the Beijing Outstanding Talent Training Fund.

Dr. Liu received her Ph.D. degree in University of Chinese Academy of Sciences in July 2014. She received her bachelor’s degree in Sun Yat-sen University in July 2008.